|
Search concepts
|
| Selected Filters |
Search results
-
2018
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma
Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E., Jan 1 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 3, p. 230-235 6 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
2017
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases
MMAIT-IV Clinical Trial Group, Dec 1 2017, In: Annals of Surgical Oncology. 24, 13, p. 3991-4000 10 p.Research output: Contribution to journal › Article › peer-review
39 Scopus citations -
2012
Ipilimumab pharmacotherapy in patients with metastatic melanoma
Jeter, J. M., Cranmer, L. D. & Hersh, E. M., 2012, In: Clinical Medicine Insights: Oncology. 6, p. 275-286 12 p.Research output: Contribution to journal › Review article › peer-review
8 Scopus citations -
2011
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
Hersh, E. M., O'Day, S. J., Powderly, J., Khan, K. D., Pavlick, A. C., Cranmer, L. D., Samlowski, W. E., Nichol, G. M., Yellin, M. J. & Weber, J. S., Jun 1 2011, In: Investigational New Drugs. 29, 3, p. 489-498 10 p.Research output: Contribution to journal › Article › peer-review
224 Scopus citations